Podcast

The IMID Forum

Author: The Immune-Mediated Inflammatory Disease Forum
Feed episode count: 414
Official site: https://imidforum.com/
RSS: https://feeds.soundcloud.com/users/soundcloud:users:176191917/sounds.rss
JSON: /v1/public/podcasts/the-imid-forum-981476
Markdown: /podcast/the-imid-forum-981476.md

Summary

Keeping you up to date with the latest and most i…

Episodes

Jul 30, 2026 · not_requested

Discussing RA: Advanced therapy outcomes in RA

Duration seconds: 1646
Source: https://soundcloud.com/imidforum/discussing-ra-advanced-therapy

HTML Markdown JSON

Jul 22, 2026 · not_requested

Author Interview: Professor Laura Coates, July 2026

Duration seconds: 1605
Source: https://soundcloud.com/imidforum/author-interview-professor-3

HTML Markdown JSON

Jul 16, 2026 · not_requested

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Duration seconds: 1428
Source: https://soundcloud.com/imidforum/discussing-axspa-long-term

HTML Markdown JSON

Jul 9, 2026 · not_requested

Author Interview: Dr Murat Torgutalp, June 2026

Duration seconds: 1767
Source: https://soundcloud.com/imidforum/author-interview-dr-murat

HTML Markdown JSON

Jun 25, 2026 · not_requested

Discussing RA: Infectious complications of RA treatments

Duration seconds: 584
Source: https://soundcloud.com/imidforum/discussing-ra-infectious

HTML Markdown JSON

Jun 23, 2026 · not_requested

Author Interview: Doctor Chung-Mao Kao, May 2026

Duration seconds: 829
Source: https://soundcloud.com/imidforum/author-interview-doctor-chung

HTML Markdown JSON

Jun 18, 2026 · not_requested

Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement

Duration seconds: 783
Source: https://soundcloud.com/imidforum/discussing-psa-personalising

HTML Markdown JSON

Jun 12, 2026 · not_requested

EULAR 2026 Review Podcast

Duration seconds: 2376
Source: https://soundcloud.com/imidforum/eular-2026-review-podcast

HTML Markdown JSON

Jun 6, 2026 · not_requested

EULAR 2026 Day 4 Highlights Podcast

Duration seconds: 290
Source: https://soundcloud.com/imidforum/eular-2026-day-4-highlights

HTML Markdown JSON

Jun 5, 2026 · not_requested

EULAR 2026 Day 3 Highlights Podcast

Duration seconds: 206
Source: https://soundcloud.com/imidforum/eular-2026-day-3-highlights

HTML Markdown JSON

Jun 4, 2026 · not_requested

EULAR 2026 Day 2 Highlights Podcast

Duration seconds: 332
Source: https://soundcloud.com/imidforum/eular-2026-day-2-highlights

HTML Markdown JSON

Jun 3, 2026 · not_requested

EULAR 2025 Day 1 Highlights Podcast

Duration seconds: 337
Source: https://soundcloud.com/imidforum/eular-2025-day-1-highlights

HTML Markdown JSON

May 28, 2026 · not_requested

Discussing RA: Comparative outcomes with upadacitinib in RA

Duration seconds: 513
Source: https://soundcloud.com/imidforum/discussing-ra-comparative

HTML Markdown JSON

May 27, 2026 · not_requested

EULAR 2026 Preview Podcast

Duration seconds: 1344
Source: https://soundcloud.com/imidforum/eular-2025-preview-podcast-1

HTML Markdown JSON

May 15, 2026 · not_requested

Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis

Duration seconds: 1315
Source: https://soundcloud.com/imidforum/discussing-axspa-biologic

HTML Markdown JSON

Apr 30, 2026 · not_requested

Author Interview: Professor Valentino Paci, April 2026

Duration seconds: 2426
Source: https://soundcloud.com/imidforum/author-interview-professor-2

HTML Markdown JSON

Apr 30, 2026 · not_requested

Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure

Duration seconds: 868
Source: https://soundcloud.com/imidforum/discussing-ra-eular

HTML Markdown JSON

Apr 14, 2026 · not_requested

Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile

Duration seconds: 992
Source: https://soundcloud.com/imidforum/discussing-psa-bimekizumab-in

HTML Markdown JSON

Apr 9, 2026 · not_requested

Author Interview: Professor Helena Marzo-Ortega, March 2026

Duration seconds: 2259
Source: https://soundcloud.com/imidforum/author-interview-professor-1

HTML Markdown JSON

Mar 26, 2026 · not_requested

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

Duration seconds: 602
Source: https://soundcloud.com/imidforum/discussing-ra-malignancy-risk

HTML Markdown JSON

Mar 19, 2026 · not_requested

Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers

Duration seconds: 2009
Source: https://soundcloud.com/imidforum/discussing-axspa-symptom

HTML Markdown JSON

Mar 12, 2026 · not_requested

Author Interview: Doctor Carlo Tur, February 2026

Duration seconds: 1775
Source: https://soundcloud.com/imidforum/author-interview-doctor-carlo

HTML Markdown JSON

Mar 5, 2026 · not_requested

Author Interview - Professor Andrew Cope, 2026

Duration seconds: 1490
Source: https://soundcloud.com/imidforum/author-interview-professor

HTML Markdown JSON

Feb 27, 2026 · not_requested

Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA

Duration seconds: 518
Source: https://soundcloud.com/imidforum/discussing-ra-pain-outcomes

HTML Markdown JSON

Feb 13, 2026 · not_requested

Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes

Duration seconds: 1250
Source: https://soundcloud.com/imidforum/discussing-psa-risankizumab

HTML Markdown JSON

Feb 3, 2026 · not_requested

Author Interview: Professor Matthew Brown, 2026

Duration seconds: 1109
Source: https://soundcloud.com/imidforum/author-interview-professor-matthew-brown-2026

HTML Markdown JSON

Jan 29, 2026 · not_requested

Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis

Duration seconds: 560
Source: https://soundcloud.com/imidforum/discussing-ra-long-term-effectiveness-and-sex-differences-of-jak-inhibitors-in-rheumatoid-arthritis

HTML Markdown JSON

Dec 18, 2025 · not_requested

Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA

Duration seconds: 1350
Source: https://soundcloud.com/imidforum/discussing-ra-upa-outcomes-and-the-impact-of-gcs-on-targeted-therapies-in-ra

HTML Markdown JSON

Dec 11, 2025 · not_requested

Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab

Duration seconds: 788
Source: https://soundcloud.com/imidforum/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab

HTML Markdown JSON

Dec 4, 2025 · not_requested

Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA

Duration seconds: 1247
Source: https://soundcloud.com/imidforum/discussing-psa-uveitis-risk-and-treatment-sequencing-outcomes-in-axspa-and-psa

HTML Markdown JSON

Nov 27, 2025 · not_requested

Discussing RA: Real-world evaluation of JAKi efficacy, persistence, and cardiovascular safety in RA

Duration seconds: 585
Source: https://soundcloud.com/imidforum/discussing-ra-real-world-evaluation-of-jaki-efficacy-persistence-and-cardiovascular-safety-in-ra

HTML Markdown JSON

Nov 20, 2025 · not_requested

Author Interview: Professor Filip Rob, 2025

Duration seconds: 1507
Source: https://soundcloud.com/imidforum/author-interview-professor-filip-rob-2025

HTML Markdown JSON

Nov 16, 2025 · not_requested

Webinar Highlights: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs: Part 2

Duration seconds: 1022
Source: https://soundcloud.com/imidforum/webinar-highlights-advancing-patient-care-through-an-interdisciplinary-approach-to-imids-part-2

HTML Markdown JSON

Nov 13, 2025 · not_requested

Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

Duration seconds: 877
Source: https://soundcloud.com/imidforum/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis

HTML Markdown JSON

Nov 6, 2025 · not_requested

Discussing RA: Long-term management of elderly patients with RA treated with tocilizumab

Duration seconds: 315
Source: https://soundcloud.com/imidforum/discussing-ra-long-term-management-of-elderly-patients-with-ra-treated-with-tocilizumab

HTML Markdown JSON

Nov 5, 2025 · not_requested

ACR 2025 Review Podcast

Duration seconds: 2415
Source: https://soundcloud.com/imidforum/acr-2025-review-podcast

HTML Markdown JSON

Oct 29, 2025 · not_requested

ACR Daily Highlights Day 4

Duration seconds: 108
Source: https://soundcloud.com/imidforum/acr-daily-highlights-day-4

HTML Markdown JSON